Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Fred Jean

Psychiatry Fort Myers, FL Medical Doctor

NPI 1972605558 CMS profile 647308

2789 Ortiz Ave, Fort Myers, FL 33905

Open in the dashboard

General payments

$6,082

276 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Fred Jean of Fort Myers, FL is reported in the CMS Open Payments database as having received $6,082 across 276 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $923 21
2024 General $621 20
2023 General $772 42
2022 General $1,171 61
2021 General $1,234 67
2020 General $680 34
2019 General $681 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Fred Jean
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Fred Jean were reported at $923. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Fred Jean Psychiatry median Middle half National median
2019 $681 $184 $59–$605 $163
2020 $680 $119 $36–$372 $114
2021 $1,234 $143 $43–$576 $132
2022 $1,171 $153 $50–$590 $149
2023 $772 $170 $56–$651 $160
2024 $621 $179 $57–$673 $164
2025 $923 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Teva Pharmaceuticals USA, Inc. $1,404 40 payments
  2. AbbVie, Inc. $974 57 payments
  3. Alkermes, Inc. $847 40 payments
  4. ITI, Inc. $630 13 payments
  5. Otsuka America Pharmaceutical, Inc. $624 37 payments
  6. Neurocrine Biosciences, Inc. $333 20 payments
  7. Sunovion Pharmaceuticals Inc. $289 19 payments
  8. Janssen Pharmaceuticals, Inc $248 14 payments
  9. Allergan Inc. $139 8 payments
  10. Lundbeck LLC $135 9 payments
  11. Other $459 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,790 272 payments
  2. Education $292 4 payments
Products named General payments · program years 2019–2025
  1. VRAYLAR $974 57 payments
  2. Austedo XR $627 10 payments
  3. ARISTADA Cns $624 33 payments
  4. ARISTADA Cns $624 33 payments
  5. ARISTADA INITIO $526 27 payments
  6. LYBALVI Cns $521 24 payments
  7. ARISTADA Cns $424 22 payments
  8. ARISTADA Cns $424 22 payments
  9. LYBALVI Cns $423 18 payments
  10. ABILIFY MAINTENA $382 21 payments
  11. Other $3,794 187 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 18 drugs

Part D claims

482

Median for Psychiatry: 574

Drug cost

$66,966

Median for Psychiatry: $27,624

Branded share of claims

22.6%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Abilify Maintena Aripiprazole Brand 15 $39,922
Rexulti Brexpiprazole Brand 12 $20,485
Aripiprazole Generic 30 $1,683
Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine Brand 22 $775
Clonazepam Generic 57 $701
Duloxetine Hcl Generic 25 $504
Risperidone Generic 38 $489
Bupropion Xl Bupropion Hcl Brand 44 $463
Alprazolam Generic 58 $354
Venlafaxine Hcl Er Venlafaxine Hcl Brand 16 $326

The 10 drugs with the highest cost, of 18 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$18,682

Medicare's payments for the services billed

Medicare patients

34

Average age 61

Services billed

595

19 women, 15 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 65%
High blood pressure 62%
Arthritis 41%
Diabetes 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Austedo XR
  • Teva Pharmaceuticals USA, Inc. $238
$238 — —
CAPLYTA
  • ITI, Inc. $125
$125 — —
ABILIFY ASIMTUFII
  • Otsuka America Pharmaceutical, Inc. $61
$61 — —
REXULTI
  • Otsuka America Pharmaceutical, Inc. $50
$50 12 —
VRAYLAR
  • AbbVie, Inc. $42
$42 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

276 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record